Peptide Association LLC is a for-profit company. We receive compensation from the clinical providers listed on this site. We are not an accrediting body, a licensing board, or a government-affiliated organization. See exactly how we make money.
Peptide Association LLC is a for-profit company. We receive compensation from the clinical providers listed on this site. We are not an accrediting body, a licensing board, or a government-affiliated organization. See exactly how we make money.
Articles, guides, and regulatory updates from our community.
A 2026 study in 3 Biotech fabricated a BPC-157 chitosan hydrogel showing promising antibacterial and biocompatible properties for future biomedical use.
By Peptide Association Research Team
New research explores how mitochondrial dysfunction drives postoperative cognitive decline and which peptide-based therapies show promise in preclinical studies.
By Peptide Association Research Team
New research explores a BPC-157 chitosan hydrogel with strong encapsulation, antibacterial properties, and biocompatibility. Learn what the findings suggest.
By Peptide Association Research Team
A 2026 study in 3 Biotech fabricated a BPC-157 chitosan hydrogel with promising antibacterial and drug-delivery properties. Here's what the research suggests.
By Peptide Association Research Team
New research links perioperative opioid use to hippocampal mitochondrial dysfunction and cognitive decline in aged rats. Learn what the findings mean for patients.
By Peptide Association Research Team
A 2026 study published in 3 Biotech characterized a BPC-157 chitosan hydrogel showing promising antibacterial and biocompatible properties for biomedical use.
By Peptide Association Research Team
A 2026 study in 3 Biotech fabricated a BPC-157 chitosan hydrogel showing strong encapsulation, antibacterial activity, and biocompatibility in lab testing.
By Peptide Association Research Team
A 2026 study in 3 Biotech found that a BPC-157 chitosan hydrogel showed promising antibacterial and biocompatible properties. Learn what researchers discovered.
By Peptide Association Research Team
New research raises questions about impurity profiles and immunogenicity risks in compounded and follow-on GLP-1 receptor agonists like semaglutide and liraglutide.
By Peptide Association Research Team
A 2026 review study explores the complex mechanisms behind acute-on-chronic liver failure, including immune dysfunction and emerging experimental therapies.
By Peptide Association Research Team
A 2026 review explores the complex mechanisms behind acute-on-chronic liver failure, including immune dysfunction and emerging experimental therapies.
By Peptide Association Research Team
New research explores how antimicrobial peptide-functionalized nanoparticles activated by near-infrared light may help eradicate biofilms in diabetic wounds.
By Peptide Association Research Team
New research suggests a biomimetic hematoma scaffold may regenerate large bone defects using a fraction of the rhBMP-2 dose currently used in clinical practice.
By Peptide Association Research Team
A 2026 clinical study suggests HMB supplementation may influence inflammatory patterns and intracellular amino acid synthesis in critically ill ICU patients.
By Peptide Association Research Team
A 2026 case report links long-acting growth hormone therapy to severe DKA in a child without prior diabetes. Learn what clinicians and patients should know.
By Peptide Association Research Team
New research explores antimicrobial peptide-functionalized nanoparticles activated by NIR light to fight biofilms in diabetic wounds. Learn what the study found.
By Peptide Association Research Team
A 2026 case report links long-acting growth hormone therapy to severe DKA in a teen without prior diabetes. Learn what the research means for patients.
By Peptide Association Research Team
New research explores how antimicrobial peptide-functionalized nanoparticles activated by near-infrared light may help eradicate biofilms in diabetic wounds.
By Peptide Association Research Team
A 2026 case report links long-acting growth hormone therapy to severe DKA in a child without prior diabetes. Learn what the research suggests for patient safety.
By Peptide Association Research Team
New research explores NIR-activated antimicrobial peptide nanoparticles that may help eradicate biofilms in diabetic wounds without promoting antibiotic resistance.
By Peptide Association Research Team
A 2026 case report links long-acting growth hormone therapy to severe DKA in a child without prior diabetes. Learn what clinicians and patients should know.
By Peptide Association Research Team
A 2026 case report reveals a child developed severe DKA after starting long-acting growth hormone therapy. Learn what clinicians and patients should know.
By Peptide Association Research Team
A landmark 2025 BMJ network meta-analysis comparing 19 obesity drugs across 262 trials reveals key trade-offs between weight loss, side effects, and heart health.
By Peptide Association Research Team
New research explores continuous spin-freeze-drying scale-out for PEGylated peptide formulations, showing consistent quality from lab to GMP manufacturing.
By Peptide Association Research Team